Recombinant Bacillus subtilis Small, acid-soluble spore protein M (sspM)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Bacillus subtilis Small, Acid-Soluble Spore Protein M (SspM)

Bacillus subtilis is a Gram-positive bacterium well-regarded for its capacity to form endospores, which are highly resistant to environmental stressors . Spores of Bacillus subtilis have garnered significant interest because of their stress resistance, making them a platform for biotechnological applications, including but not limited to, stabilized and recyclable enzymes, drug delivery, synthetic biology, and material sciences . Small acid-soluble spore proteins (SASPs) are a family of proteins found in bacteria spores that protect DNA from damage and are synthesized during sporulation. SspM is one of the SASPs. Recombinant SspM refers to SspM produced using recombinant DNA technology, where the gene encoding SspM is introduced into a host organism (e.g., B. subtilis or E. coli) to produce the protein in large quantities .

Recombinant Production of SspM

  • Genetic Manipulation: Bacillus subtilis is amenable to genetic manipulation, which facilitates the recombinant production of proteins . The gene encoding SspM can be cloned into a plasmid vector and introduced into Bacillus subtilis or another suitable host organism .

  • Expression Systems: Various expression systems are available for recombinant protein production in Bacillus subtilis, including inducible promoters and constitutive promoters . The choice of expression system depends on the desired level of protein expression and the specific application .

  • Purification: Recombinant SspM can be purified from cell lysates using standard protein purification techniques, such as affinity chromatography, ion exchange chromatography, and size exclusion chromatography .

Applications of Recombinant Bacillus subtilis and SspM

Bacillus subtilis and its recombinant proteins, including SspM, have diverse applications across various fields :

  • Vaccine Development: Recombinant Bacillus subtilis spores can be engineered to display antigens on their surface, making them potential candidates for oral vaccines . The spores can interact with immune cells in the gut-associated lymphoid tissue (GALT), triggering an immune response .

  • Biopesticides: Bacillus subtilis strains and their metabolites exhibit antimicrobial activity against plant pathogens, making them useful as biopesticides . Recombinant spores displaying antimicrobial peptides or enzymes can enhance their efficacy in controlling plant diseases .

  • Enzyme Production: Bacillus subtilis is a workhorse for industrial enzyme production due to its ability to secrete large amounts of proteins into the extracellular medium . Recombinant strains can be engineered to produce specific enzymes with improved properties for various industrial applications .

  • Drug Delivery: Bacillus subtilis spores can be used as carriers for targeted drug delivery . The spores can be modified to encapsulate therapeutic agents and release them at specific sites in the body .

  • Biosensors: Recombinant Bacillus subtilis strains can be engineered to produce biosensors for detecting specific compounds or environmental conditions . These biosensors can be used in environmental monitoring, food safety, and medical diagnostics .

Immunogenicity of Recombinant Bacillus subtilis

  • Immune Responses: Recombinant Bacillus subtilis can stimulate both mucosal and systemic immune responses . Intranasal administration of recombinant Bacillus subtilis expressing viral antigens has been shown to induce IgA and IgG antibody production, as well as T cell-mediated immunity .

  • Adjuvant Effects: Bacillus subtilis spores possess intrinsic adjuvant properties, enhancing the immune response to co-administered antigens . The spore surface can interact with immune cells, activating signaling pathways that promote inflammation and adaptive immunity .

  • Vaccine Delivery: Recombinant Bacillus subtilis has been explored as a vaccine delivery system for various infectious diseases, including pseudorabies virus (PRV) in swine . Intranasal administration of recombinant Bacillus subtilis expressing PRV antigens has been shown to protect against viral challenge .

Antimicrobial Compounds Produced by Bacillus subtilis

Bacillus subtilis produces a variety of antimicrobial compounds, including bacteriocins, lipopeptides, polyketides, and volatile organic compounds . These compounds exhibit activity against a broad spectrum of bacteria, fungi, and viruses .

  • Bacteriocins: Ribosomally synthesized peptides that inhibit the growth of closely related bacteria .

  • Lipopeptides: Non-ribosomally synthesized peptides with a lipid moiety that disrupts microbial membranes .

  • Polyketides: Complex secondary metabolites with diverse structures and bioactivities .

  • Volatile Organic Compounds (VOCs): Small molecules that inhibit microbial growth or interfere with microbial communication .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
sspM; BSU22290Small; acid-soluble spore protein M; SASP M
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-34
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bacillus subtilis (strain 168)
Target Names
sspM
Target Protein Sequence
MKTRPKKAGQ QKKTESKAID SLDKKLGGPN RPST
Uniprot No.

Target Background

Database Links
Subcellular Location
Spore core.

Q&A

What is the genetic organization and regulation of sspM in B. subtilis?

sspM is one of several genes encoding minor small, acid-soluble proteins (SASP) unique to spores of Bacillus subtilis. Unlike some other SASP genes that form operons, sspM is monocistronic, meaning it is transcribed as a single gene unit. Its transcription is primarily, if not exclusively, controlled by RNA polymerase with the forespore-specific sigma factor, sigma(G) .

The promoter region of sspM contains sequences centered 10 and 35 nucleotides upstream of its 5'-end that show homology to the -10 and -35 sequences recognized by sigma(G) . This specific regulatory mechanism ensures that sspM is expressed only in the forespore compartment of sporulating cells, which is critical for proper timing of protein production during the sporulation process.

How does sspM function differ from other SASP proteins in B. subtilis spores?

The sspM gene encodes one of the minor small, acid-soluble proteins in B. subtilis spores. Unlike some other SASP proteins that play crucial roles in spore properties, deletion mutations in sspM have no discernible effect on sporulation, spore properties, or spore germination . This contrasts with some other SASP proteins, such as those encoded by sspI, where deletion can cause significant defects in spore outgrowth .

The functional redundancy observed with sspM suggests that while it belongs to the SASP family, its specific contribution to spore biology may be compensated by other proteins or it may have specialized functions that are not apparent under standard laboratory conditions.

What expression systems are most effective for recombinant protein production in B. subtilis?

Several expression systems have proven effective for recombinant protein production in B. subtilis:

Table 1. Key Expression Systems for B. subtilis

Expression System TypeExamplesAdvantagesBest Applications
Constitutive promotersP43, PvegContinuous expression without inducersStable, non-toxic proteins
Double promotersPgsiB-HpaII, PamyE-sodA-fusAEnhanced expression levelsHigh-yield production
Functional synthetic promotersPBH4, mutant promoters derived from PylbPResistance to imperfect growth conditionsBiotechnological processes causing cellular stress
Inducible systemsIPTG-inducible, xylose-inducibleControlled expression timingPotentially toxic proteins
Self-inducible systemsVariousReduced cost, simplified productionIndustrial-scale applications

For recombinant sspM expression specifically, systems utilizing sigma(G)-dependent promoters would provide the most natural regulation, while inducible systems offer greater experimental control . The P43 promoter is particularly useful as a benchmark, as it is regularly used in comparative studies to measure the strength of different promoters in B. subtilis .

What advantages does B. subtilis offer as a host for recombinant sspM production?

B. subtilis presents several key advantages for recombinant protein production:

  • GRAS (Generally Recognized As Safe) status certified by the FDA, making it free of exotoxins and endotoxins .

  • Remarkable innate ability to absorb and incorporate exogenous DNA into its genome .

  • Diverse codon reading capability that contributes to the expression of heterologous genes without additional steps .

  • Well-established secretion systems allowing for extracellular production of proteins, simplifying purification .

  • Extensively characterized genetics with numerous available expression vectors and genetic tools .

  • Capacity for high-yield protein production, reaching gram-per-liter ranges in laboratory settings and up to 25 grams per liter under optimized fermentation conditions .

For sspM specifically, the natural regulatory mechanisms governing SASP expression in B. subtilis provide a foundation for controlled production of this spore protein.

What methodologies are most effective for optimizing recombinant sspM expression in B. subtilis?

For optimal recombinant sspM expression, researchers should consider a multi-faceted approach:

Table 2. Optimization Strategies for Recombinant Protein Expression in B. subtilis

StrategySpecific ApproachPotential ImprovementReference
Promoter EngineeringDual promotersUp to 10.72 U/mg^-1 DCW (for amidase)
Secretion EnhancementPrsA overexpression2.5-10 fold increase
Strain EngineeringProtease gene knockouts (WB600/WB800)Reduced proteolysis
Secretion MachineryRasP overexpression2.5-10 fold increase
Signal Peptide OptimizationDeletion of signal peptidase genes (sipS/sipU)Enhanced processing rates

How can genetic interaction analysis inform the study of sspM function in B. subtilis?

Recent advances in genetic interaction (GI) analysis using double-CRISPRi technology offer powerful approaches to understanding gene function in B. subtilis. This methodology can be particularly valuable for studying sspM:

  • Systematic Interaction Mapping: Double-CRISPRi allows for quantification of genetic interactions at scale, revealing functional relationships between sspM and other genes. This approach has discovered >1000 known and novel genetic interactions in the B. subtilis envelope .

  • Essential Gene Analysis: Unlike traditional knockout methods, CRISPRi can target essential genes, allowing researchers to explore potential interactions between sspM and genes critical for cell viability .

  • Paralog Function Differentiation: This approach has revealed distinct roles of paralogous genes such as the mreB and mbl actin homologs . Similar analysis could identify functional relationships between sspM and other SASP family members.

  • Implementation Protocol:

    • Design sgRNAs targeting sspM and potential interacting genes

    • Construct dual-expression CRISPRi systems

    • Measure growth phenotypes in single and double knockdowns

    • Calculate genetic interaction scores to identify synergistic, antagonistic, or epistatic relationships

What analytical techniques are most appropriate for characterizing recombinant sspM structure and function?

Comprehensive characterization of recombinant sspM requires multiple analytical approaches:

  • Structural Analysis:

    • Circular Dichroism (CD) spectroscopy to determine secondary structure elements

    • X-ray crystallography or NMR for high-resolution structural determination

    • Mass spectrometry for accurate molecular weight determination and post-translational modifications

  • Functional Analysis:

    • DNA-binding assays to assess interaction with spore DNA

    • Thermal stability assays to evaluate contribution to spore heat resistance

    • UV resistance assays to determine protection against radiation damage

    • Spore germination kinetics measurements to assess impacts on outgrowth

  • Interaction Studies:

    • Pull-down assays to identify protein partners

    • Bacterial two-hybrid assays to verify specific interactions

    • ChIP-seq to map DNA binding sites in vivo

  • Localization Analysis:

    • Fluorescence microscopy using fusion proteins to track localization during sporulation

    • Immunogold electron microscopy for high-resolution localization within the spore

Current evidence suggests that sspM deletion has no discernible effect on sporulation, spore properties, or spore germination , but more sensitive analytical techniques may reveal subtle phenotypes not detected in earlier studies.

How do mutations in sspM affect spore resistance compared to mutations in other SASP genes?

While direct comparative data on sspM versus other SASP mutations is limited in the provided search results, we can construct an informative analysis based on available information:

Table 3. Comparative Effects of SASP Gene Mutations on B. subtilis Spores

SASP GeneEffect on SporulationEffect on Spore PropertiesEffect on GerminationEffect on OutgrowthReference
sspMNo discernible effectNo discernible effectNo discernible effectNo discernible effect
sspINo discernible effectNo discernible effectNo discernible effectSignificant defect
sspKNo discernible effectNo discernible effectNo discernible effectNo discernible effect
sspONo discernible effectNo discernible effectNo discernible effectNo discernible effect
sspPLikely no effectLikely no effectLikely no effectUnknown

This comparative analysis highlights the functional redundancy among some SASP proteins (sspM, sspK, sspO) versus the specific role of sspI in spore outgrowth. Research methodology to further investigate these differences would include:

  • Creating combinatorial SASP gene deletions to assess potential synergistic effects

  • Challenging spores with various stressors (heat, radiation, chemicals) to detect subtle resistance phenotypes

  • Using high-resolution microscopy and proteomics to identify structural differences in mutant spores

  • Measuring gene expression patterns during outgrowth to identify compensatory responses

What are the challenges and solutions in purifying recombinant sspM from B. subtilis?

Purifying recombinant sspM from B. subtilis presents several challenges with corresponding methodological solutions:

Challenges:

  • Proteolytic degradation due to B. subtilis' extensive extracellular protease production

  • Potential incorporation into forming spores during sporulation

  • DNA binding properties that may complicate purification

  • Relatively small size making it difficult to separate from other small proteins

Methodological Solutions:

  • Host Strain Selection:

    • Use protease-deficient strains like WB600 or WB800

    • Consider using sporulation-deficient strains to prevent sspM incorporation into spores

  • Expression Strategy:

    • Express sspM with an affinity tag (His6, GST, or FLAG) for simplified purification

    • Place the tag at the C-terminus to avoid interfering with potential N-terminal functional domains

    • Use an inducible promoter system not dependent on sporulation signals

  • Purification Protocol:

    • Two-step purification combining affinity chromatography with size exclusion

    • Include DNA-degrading enzymes (DNase I) in early purification steps

    • Add protease inhibitors throughout the purification process

    • Consider on-column refolding if inclusion bodies form

  • Quality Control:

    • Verify purified protein by mass spectrometry

    • Assess DNA contamination by measuring A260/A280 ratio

    • Confirm activity through DNA protection assays

This comprehensive purification strategy addresses the specific challenges posed by sspM's properties and B. subtilis as an expression host, while providing multiple quality control checkpoints.

How can sspM be engineered as part of synthetic biology applications in B. subtilis?

Engineering sspM for synthetic biology applications represents an emerging frontier with several promising approaches:

  • Using sspM's Promoter for Controlled Expression:

    • The sigma(G)-dependent promoter of sspM could be harnessed for forespore-specific gene expression

    • This would allow targeted expression of proteins exclusively during the late stages of sporulation

    • Applications include spore display technology and production of proteins that would be toxic during vegetative growth

  • Engineering sspM as a DNA Protection Module:

    • While sspM deletion alone shows no phenotype, engineered variants could provide enhanced DNA protection

    • Custom sspM variants could be designed to protect specific DNA sequences or structures

    • Applications include improved spore resistance for bioremediation or long-term data storage in synthetic spores

  • Methodology for sspM Engineering:

    • Use high-throughput screening approaches similar to those described for other B. subtilis proteins

    • Apply directed evolution to evolve sspM variants with altered binding properties

    • Implement computational design to predict mutations that would enhance specific functions

The powerful genetic tools available for B. subtilis, including the double-CRISPRi system for genetic interaction analysis , provide a strong foundation for these engineering efforts.

How do genomic and transcriptomic analyses inform our understanding of sspM regulation in industrial B. subtilis strains?

Integrated genomic and transcriptomic analyses offer powerful insights into sspM regulation, particularly in industrial strains:

  • Comparative Genomic Analysis:

    • Genome sequencing of industrial B. subtilis strains reveals mutations that may affect sspM expression

    • For example, studies of riboflavin-overproducing B. subtilis strains identified mutations in regulatory genes that could indirectly impact sporulation genes like sspM

    • Methodology includes whole-genome sequencing followed by comparative analysis against reference strains

  • Transcriptome Profiling:

    • RNA-seq analysis during sporulation can identify co-regulated genes and regulatory networks controlling sspM

    • Transcriptome sequencing has successfully identified regulatory mutations in industrial strains

    • Time-course experiments during sporulation can reveal the precise timing of sspM expression relative to other sporulation genes

  • Integration with Proteomics:

    • Combining transcriptome data with proteome analysis can reveal post-transcriptional regulation

    • This integrated approach has been used to characterize riboflavin-overproducing B. subtilis

    • Methods include RNA-seq, quantitative proteomics, and computational integration of datasets

Understanding these regulatory mechanisms in industrial strains is particularly valuable for designing expression strategies that avoid interference with sspM and other sporulation genes, ensuring stable recombinant protein production.

What strategies can resolve poor expression of recombinant sspM in B. subtilis?

When facing poor expression of recombinant sspM, researchers should consider these methodological approaches:

  • Promoter Optimization:

    • Test multiple promoter systems, including constitutive (P43, Pveg), inducible, and synthetic promoters

    • Consider dual promoter systems like PgsiB-HpaII that have shown high efficiency for other recombinant proteins

    • Implement gradual evolution screening strategies like SETarSCoP to identify robust promoter variants

  • Codon and RBS Optimization:

    • Analyze and optimize the ribosome binding site strength

    • Adjust codon usage to match B. subtilis preferences

    • Test various 5' UTR designs to optimize translation initiation

  • Expression Strain Engineering:

    • Use protease-deficient strains like WB600 or WB800

    • Consider sigma factor-overexpressing strains to enhance promoter recognition

    • Test strains with modified metabolic pathways to ensure adequate precursor supply

  • Culture Conditions Optimization:

    • Systematically test different media compositions, temperatures, and induction conditions

    • For sporulation-associated proteins like sspM, carefully time induction relative to the sporulation cycle

    • Implement fed-batch or continuous culture systems to maintain optimal growth phase

Table 4. Troubleshooting Guide for Poor Recombinant Protein Expression in B. subtilis

ProblemPotential CauseSolution StrategyExpected Outcome
Low expression levelWeak promoterTest dual promoters or engineered synthetic promoters2-26× increase in expression
Protein degradationProtease activityUse protease-deficient strains (WB600/WB800)Reduced degradation, higher yield
Poor translationSuboptimal RBSOptimize RBS sequence and spacingImproved translation initiation
Growth inhibitionMetabolic burdenUse balanced expression systems with controlled inductionMaintained growth with adequate expression
Premature sporulationNutrient limitationOptimize media composition and feeding strategyExtended vegetative growth phase

How can researchers differentiate between native and recombinant sspM in experimental analyses?

Differentiating between native and recombinant sspM requires strategic experimental design:

  • Epitope Tagging Approaches:

    • Add epitope tags (His, FLAG, HA) to recombinant sspM for specific detection

    • Validate that tags do not interfere with protein function through complementation assays

    • Use tag-specific antibodies for western blotting, immunoprecipitation, or immunofluorescence

  • Genetic Background Selection:

    • Express recombinant sspM in a clean sspM deletion background

    • Use CRISPR/Cas9 or traditional homologous recombination to create marker-free sspM knockouts

    • Verify deletion through PCR and sequencing before introducing recombinant constructs

  • Protein Sequence Modification:

    • Introduce conservative amino acid substitutions that don't affect function but enable differentiation

    • Create fusion proteins with fluorescent reporters (GFP, mCherry) for visualization

    • Design recombinant sspM with altered molecular weight for easy separation on gels

  • Analytical Methods:

    • Employ mass spectrometry to identify specific peptides unique to recombinant variants

    • Use 2D gel electrophoresis to separate based on both molecular weight and isoelectric point

    • Implement immunoaffinity purification to isolate tagged recombinant sspM

These approaches enable researchers to clearly distinguish between native and recombinant sspM, allowing precise analysis of recombinant protein behavior without interference from the endogenous protein.

What emerging technologies will advance our understanding of sspM function in B. subtilis?

Several cutting-edge technologies are poised to transform research on sspM function:

  • Single-Cell Technologies:

    • Single-cell RNA-seq during sporulation to capture cell-to-cell variability in sspM expression

    • Time-lapse fluorescence microscopy with tagged sspM to track dynamics during sporulation

    • Single-molecule tracking to observe sspM interactions with DNA in real-time

  • Structural Biology Advances:

    • Cryo-electron microscopy to visualize sspM in complex with DNA and other spore proteins

    • AlphaFold2 and other AI-based structure prediction to model sspM interactions

    • Hydrogen-deuterium exchange mass spectrometry to map dynamic protein-protein interactions

  • Genome Engineering Tools:

    • CRISPR-based base editors for precise engineering of sspM variants

    • Double-CRISPRi systems for comprehensive genetic interaction mapping

    • Multiplexed genome engineering to create combinatorial mutations in SASP genes

  • Systems Biology Approaches:

    • Multi-omics integration to place sspM in broader sporulation networks

    • Metabolic flux analysis to understand energy allocation during sspM expression

    • Mathematical modeling of the sporulation process including sspM dynamics

These technologies will enable researchers to address fundamental questions about sspM function that have remained elusive with traditional approaches, potentially revealing subtle phenotypes and interactions masked by functional redundancy with other SASP proteins.

How might understanding sspM contribute to broader applications of B. subtilis in biotechnology?

The study of sspM can inform several broader biotechnological applications:

  • Spore-Based Biotechnology:

    • Engineering sspM and other SASP proteins to create spores with enhanced stability for probiotics or bioremediation

    • Developing spore-based display systems where sspM interactions are leveraged for protein presentation

    • Creating spores with custom DNA protection properties for specialized applications

  • Synthetic Biology Platforms:

    • Using knowledge of sspM regulation to design sophisticated genetic circuits activated during sporulation

    • Developing forespore-specific expression systems based on sspM promoter architecture

    • Engineering synthetic SASP proteins with novel functions beyond natural SASPs

  • Protein Production Systems:

    • Applying insights from sspM expression to improve recombinant protein production timing and yield

    • Developing expression systems that leverage the natural compartmentalization during sporulation

    • Creating production strains with modified SASP profiles for specialized protein production

  • Biological Data Storage:

    • Using engineered sspM variants to protect synthetic DNA encoding information

    • Developing long-term biological archiving systems leveraging spore longevity

    • Creating information encoding/retrieval systems based on SASP-DNA interactions

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.